Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» NAS:VWR's 30-Y Financials

Financials (Next Earnings Date: 2018-11-03 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2017

VWR Guru Trades in Q1 2017

Joel Greenblatt 46,582 sh (+120.69%)
Robert Olstein 506,824 sh (+17.22%)
Jim Simons 186,000 sh (-13.25%)
Paul Tudor Jones 11,611 sh (-27.17%)
Columbia Wanger 1,390,129 sh (-41.92%)
» More
Q2 2017

VWR Guru Trades in Q2 2017

Mario Gabelli 62,600 sh (New)
David Dreman 1,196 sh (New)
John Paulson 2,675,200 sh (New)
Jim Simons 836,700 sh (+349.84%)
Paul Tudor Jones Sold Out
Columbia Wanger Sold Out
Joel Greenblatt Sold Out
Robert Olstein 451,124 sh (-10.99%)
» More
Q3 2017

VWR Guru Trades in Q3 2017

Caxton Associates 13,800 sh (New)
Mario Gabelli 116,819 sh (+86.61%)
David Dreman 1,196 sh (unchged)
John Paulson Sold Out
Jim Simons 829,200 sh (-0.90%)
Robert Olstein 364,648 sh (-19.17%)
» More
Q4 2017

VWR Guru Trades in Q4 2017

Caxton Associates Sold Out
Robert Olstein Sold Out
Mario Gabelli Sold Out
David Dreman Sold Out
Jim Simons Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with VWR

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
David Dreman 2017-12-31 Sold Out 0.02%$33.06 - $33.25 $ 33.250%0
Robert Olstein 2017-12-31 Sold Out 1.56%$33.06 - $33.25 $ 33.250%0
Mario Gabelli 2017-12-31 Sold Out 0.02%$33.06 - $33.25 $ 33.250%0
Robert Olstein 2017-09-30 Reduce -19.17%0.36%$32.95 - $33.18 $ 33.251%364,648
Mario Gabelli 2017-09-30 Add 86.61%0.01%$32.95 - $33.18 $ 33.251%116,819
John Paulson 2017-09-30 Sold Out 1.2%$32.95 - $33.18 $ 33.251%0
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Diagnostics & Research » Diagnostics & Research    NAICS: 621511    SIC: 8099
Compare:NAS:NEOG, NAS:BRKR, MIL:DIA, NAS:SYNH, NYSE:CRL, NAS:EXAS, NAS:PRAH, XTER:AFX, SHSE:603658, NAS:FMI, NAS:DXCM, BSP:DASA3, BSP:FLRY3, NAS:ICLR, TSE:4544, SHSE:603882, SZSE:300463, NAS:MYGN, SZSE:300244, NAS:QDEL » details
Traded in other countries:VW1.Germany,
Headquarter Location:USA
VWR Corp is a distributor of laboratory products mainly in the United States and to a lesser extent in Europe. Its products include chemicals, reagents, consumables, durable products, and scientific instruments.

VWR Corp operates in the healthcare sector based in the United States. It primarily offers laboratory products mainly in the American market, while distributing a minor share abroad. It provides a suite of products such as chemicals, reagents, consumables, durable products and scientific equipment and instruments to customers in the life science, general research and applied markets, including the biopharma, agricultural, chemical, environmental, food and beverage, healthcare, microelectronic, and petrochemical industries.

Ratios

vs
industry
vs
history

Buy Back

vs
industry
vs
history

Valuation & Return

vs
industry
vs
history

More Statistics

Revenue (TTM) (Mil) $4,639.90
EPS (TTM) $ 1.14
52-Week Range $24.42 - 37.25
Shares Outstanding (Mil)131.87

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 4,707 4,863 4,970
EBIT (Mil $)
EBITDA (Mil $)
EPS ($) 1.96 1.98 2.08
EPS without NRI ($) 1.96 1.98 2.08
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: ----
Positive ROAN
Positive CFROAN
Higher ROA yoyN
CFROA > ROAN
Lower Leverage yoyN
Higher Current Ratio yoyN
Less Shares Outstanding yoyN
Higher Gross Margin yoyN
Higher Asset Turnover yoyN

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}